🇺🇸 FDA

Intelligence · Clinical Pipeline

BRIGHT MINDS BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.

Programs
116

Quick answer

BRIGHT MINDS BIOSCIENCES has 116 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate

    BRIGHT MINDS BIOSCIENCES INC.

    Benign Paroxysmal Positional Vertigo

    approved small molecule completed

    1 trial

  2. 99mTc-Macro Albumin Aggregate

    BRIGHT MINDS BIOSCIENCES INC.

    Carcinoma

    approved small molecule completed

    1 trial

  3. Adderall

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Disorder With Hyperactivity

    approved small molecule completed

    1 trial

  4. Algorithm Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved small molecule completed

    1 trial

  5. Amantadine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

  6. Antiretroviral therapy (ART)

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  7. Athena strategy

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved other active

    1 trial

  8. Atomoxetine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Disorder With Hyperactivity

    approved small molecule completed

    1 trial

  9. BUP microdose induction

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    approved small molecule terminated

    1 trial

  10. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    approved other completed

    2 trials

  11. Behavioral Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved other completed

    1 trial

  12. Behavioral: Buprenorphine/naloxone maintenance (Mtn)

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    approved other completed

    1 trial

  13. Bleomycin

    BRIGHT MINDS BIOSCIENCES INC.

    Keloid

    approved small molecule active

    1 trial

  14. Brand lamotrigine

    BRIGHT MINDS BIOSCIENCES INC.

    Epilepsy

    approved small molecule completed

    1 trial

  15. Brixadi (Injectable Buprenorphine)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  16. Buccal Buprenorphine 300 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    Analgesia

    approved small molecule active

    1 trial

  17. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    approved small molecule completed

    28 trials

  18. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-related Disorders

    approved small molecule completed

    1 trial

  19. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    approved small molecule completed

    2 trials

  20. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    approved small molecule completed

    2 trials

  21. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial

  22. Bupropion Extended Release Oral Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Postpartum Smoking Relapse

    approved small molecule active

    1 trial

  23. Bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    2 trials

  24. Buspirone

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    approved small molecule completed

    1 trial

  25. Carbamazepine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    4 trials

  26. Cefepime, Meropenem, or Piperacillin/Tazobactam

    BRIGHT MINDS BIOSCIENCES INC.

    Pneumonia

    approved small molecule terminated

    1 trial

  27. Clozapine

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  28. Cocaine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    4 trials

  29. Cocaine-Related Disorders

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    2 trials

  30. Combination NRT (Nicotine patch, Nicotine lozenge)

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  31. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  32. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Stroke

    approved small molecule completed

    1 trial

  33. Desipramine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  34. Double Blind Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule completed

    1 trial

  35. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Pregnancy Related

    approved small molecule completed

    1 trial

  36. Drug: cimetidine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    approved small molecule completed

    1 trial

  37. Duragesic reference fentanyl TDS

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  38. Egg based influenza vaccines

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    approved mab active

    1 trial

  39. Electronic Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule active

    1 trial

  40. Engerix-B 20 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved mab completed

    1 trial

  41. Erythromycin 4% topical gel formulation

    BRIGHT MINDS BIOSCIENCES INC.

    Acne Vulgaris

    approved small molecule active

    1 trial

  42. Extended-Release Buprenorphine (XRB)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  43. Extended-Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  44. Fentanyl Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Respiratory Function Loss

    approved small molecule active

    1 trial

  45. Florbetapir F 18 (18F-AV-45)

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  46. Fluoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Body Dysmorphic Disorder

    approved small molecule completed

    1 trial

  47. Fluoxetine + outpatient cognitive behavioral therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    approved small molecule completed

    1 trial

  48. Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?

116 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.